MANDATES?

There’s a lot in this message that resonates, especially the idea that people should question the true purpose of institutions like the Centers for Disease Control and Prevention and Health Canada instead of just assuming they exist purely for public benefit. When you look at how closely public health policy is tied to pharmaceutical solutions, it’s hard to ignore that the system is heavily influenced by industry. That doesn’t mean every decision is harmful, but it does suggest that the priorities of these organizations may not always be perfectly aligned with individual health, especially when profit-driven companies play such a large role in research, development, and policy direction.

The examples of Paul Thomas and Melissa Dore highlight something deeper than just isolated cases, they raise real concerns about whether informed consent is fully supported within the system. When practitioners face consequences for encouraging patients to think critically and make their own decisions, it creates the impression that there are limits to acceptable viewpoints. That’s where trust starts to break down, and it’s why more people are starting to take a step back and question whether these institutions are truly serving the public, or operating within a framework that prioritizes consistency and compliance over open, individualized care.